CEL SCI CORP (CVM) CFO receives 4,125-share stock grant in Form 4

Rhea-AI Filing Summary

CEL SCI CORP Chief Financial Officer Patricia B. Prichep received a grant or award of 4,125 shares of common stock on June 30, 2026 at a reported value of $1.04 per share. After this acquisition, she directly owns 17,489 shares of the company’s common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider PRICHEP PATRICIA B

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,125	$1.04	$4K

Holdings After Transaction: Common Stock — 17,489 shares (Direct, null)

Footnotes (1)

Key Figures

Shares granted: 4,125 shares Grant price per share: $1.04 per share Post-transaction holdings: 17,489 shares +1 more

4 metrics

Shares granted 4,125 shares Non-derivative grant to CFO on June 30, 2026

Grant price per share $1.04 per share Value reported for the 4,125-share award

Post-transaction holdings 17,489 shares CFO’s direct common stock ownership after grant

Transaction code Code A Described as Grant, award, or other acquisition

Key Terms

Grant, award, or other acquisition, Common Stock, Chief Financial Officer, non-derivative

4 terms

Grant, award, or other acquisition financial

"Transaction code A is described as Grant, award, or other acquisition."

Common Stock financial

"The reported security title for this transaction is Common Stock."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Chief Financial Officer financial

"Patricia B. Prichep is listed with the title Chief Financial Officer."

A Chief Financial Officer (CFO) is the person in charge of a company's money and financial planning. They decide how to spend, save, and invest funds to help the company grow and stay stable. Their role is important because good financial decisions keep the company healthy and successful.

non-derivative financial

"The filing classifies this transaction as a non-derivative security transaction."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/01/2026 - 08:38 AM Accepted by SEC EDGAR 07/01/2026 - 08:37 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PRICHEP PATRICIA B

(Last) (First) (Middle)

8229 BOONE BLVD., SUITE 802

(Street)

VIENNA VIRGINIA 22182

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CEL SCI CORP [ CVM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/30/2026		A		4,125	A	$1.04	17,489	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Patricia Prichep	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CEL SCI CORP (CVM) report for Patricia B. Prichep?

CEL SCI CORP reported that Chief Financial Officer Patricia B. Prichep acquired 4,125 shares of common stock as a grant or award. The transaction occurred on June 30, 2026, and is coded as a non-derivative acquisition under transaction code A.

How many CEL SCI CORP (CVM) shares does the CFO hold after this Form 4?

Following the June 30, 2026 grant, Patricia B. Prichep directly holds 17,489 shares of CEL SCI CORP common stock. This total includes the newly acquired 4,125 shares reported in the Form 4 filing as a grant or award transaction.

What was the value per share for the CEL SCI CORP CFO’s share grant?

The 4,125-share grant to CEL SCI CORP Chief Financial Officer Patricia B. Prichep was reported at $1.04 per share. This value is used in the Form 4 to indicate the price per share associated with the non-derivative acquisition transaction.

Is the CEL SCI CORP CFO’s Form 4 transaction a purchase or a grant?

The transaction is reported as a grant or award acquisition, not an open-market purchase. Form 4 lists transaction code A, described as “Grant, award, or other acquisition,” for 4,125 shares of CEL SCI CORP common stock on June 30, 2026.

Does the CEL SCI CORP CFO’s Form 4 include any derivative securities?

No derivative securities are reported in this Form 4 for CEL SCI CORP’s CFO. The filing shows only a non-derivative transaction involving 4,125 shares of common stock and indicates an empty derivativeSummary section, with no option or warrant positions listed.